Search results
Results from the WOW.Com Content Network
Fibromuscular Dysplasia Society of America is an American health charity that deals with fibromuscular dysplasia, a vascular disease. [1] [2] The society sponsors a registry of patients with fibromuscular dysplasia. [3]
Fibromuscular dysplasia (FMD) is a non-atherosclerotic, non-inflammatory disease of the blood vessels that causes abnormal growth within the wall of an artery. [1] FMD has been found in nearly every arterial bed in the body, although the most commonly affected are the renal and carotid arteries. [1] [2] [3]
Arterial dysplasia is a term that refers to a group of conditions that affect the structure and function of the arteries. [1] One of the most common types of arterial dysplasia is fibromuscular dysplasia .
Renal artery stenosis (RAS) is the narrowing of one or both of the renal arteries, most often caused by atherosclerosis or fibromuscular dysplasia.This narrowing of the renal artery can impede blood flow to the target kidney, resulting in renovascular hypertension – a secondary type of high blood pressure.
Fibromuscular dysplasia, a medical condition; Fig mosaic disease, a viral disease of fig plants; Foot-and-mouth disease, a viral disease of ungulates; Flow-mediated dilation, a physiological response, and medically diagnostic tool; Fasting mimicking diet is a diet that aims to achieve the benefits of fasting
Fibromuscular dysplasia, a disease characterized by the fibrous thickening of the renal artery Fibrous dysplasia , a disease that causes growths or lesions in one or more bones of the human body Topics referred to by the same term
Fibromuscular dysplasia of arteries; Fibromuscular dysplasia; Fibromyalgia; Fibrosarcoma; Idiopathic pulmonary fibrosis; Fibrosing mediastinitis; Fibrosis; Fibrous dysplasia of bone; Fibrous dysplasia; Fibrodysplasia ossificans progressiva; Fibula aplasia complex brachydactyly; Fibular aplasia ectrodactyly; Fibular hypoplasia femoral bowing ...
With angiography and improved recognition of the condition, diagnosis of SCAD has improved since the early 2010s. While prior studies had reported a SCAD prevalence of less than 1% in patients presenting with acute coronary syndrome, more recent data suggests the prevalence of SCAD in acute coronary syndrome patients may be between 2-4%. [28]